Jazz Pharmaceuticals plc Profit Margin

As of the most recent data (June 2026), JAZZ shows a profit margin of 20.45%. That compares with -9.91% in the prior-year period — up 306.4% year over year. That is above the Healthcare sector average of 13.89%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, JAZZ's profit margin is now 20.45% (was -9.91%) — a 306.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Jazz Pharmaceuticals plc is outperforming or lagging.

The Healthcare sector average profit margin is about 13.89%. Jazz Pharmaceuticals plc is at 20.45%, which is higher that average. That is roughly 47.2% above the sector mean. Use the comparison chart on this page to see how JAZZ stacks up against individual peers as well.

That compares with -9.91% in the prior-year period — up 306.4% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Jazz Pharmaceuticals plc with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Jazz Pharmaceuticals plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 20.45%) with ownership activity and broader fundamentals.